0364UHCPCS/CPT
No Prior Auth Required
Code is covered without prior authorization (high confidence)
A59004 — Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers
J05
L36807 — MolDX: Molecular Diagnostic Tests (MDT)
J05
A57772 — Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
J05
L38835 — MolDX: Minimal Residual Disease Testing for Cancer
J05
Ask Verity about documentation requirements, denial risks, or coverage in your state.
J09
A58918 — Billing and Coding: Molecular Pathology and Genetic Testing
J09
L39367 — Genetic Testing in Oncology: Specific Tests
J09
A59492 — Billing and Coding: Genetic Testing for Oncology
J09
L35062 — Biomarkers Overview
J12
L39365 — Genetic Testing in Oncology: Specific Tests
J12
A59491 — Billing and Coding: Genetic Testing for Oncology
J12
A58917 — Billing and Coding: Molecular Pathology and Genetic Testing
J12
L36021 — MolDX: Molecular Diagnostic Tests (MDT)
L36256 — MolDX: Molecular Diagnostic Tests (MDT)
L38814 — MolDX: Minimal Residual Disease Testing for Cancer
L38816 — MolDX: Minimal Residual Disease Testing for Cancer
L38822 — MolDX: Minimal Residual Disease Testing for Cancer
UHC-POL-molecular-oncology-hematologic-cancer-diagnosis — Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions
UMR-POL-UMR-molecular-oncology-hematologic-cancer-diagnosis — Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions
AMBETTER-CG-Onc-Tumor-Hemat.-Malig.-2025.1 — Concert Genetic Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies